Arena Pharmaceuticals   Report issue

Contributed to NME For profit Phase 1 Phase 2 Phase 3
Founded: San Diego CA United States (1977)
Status: Acquired by Pfizer (2021)

Organization Overview

First Clinical Trial
2004
NCT00104507
First Marketed Drug
2012
lorcaserin (belviq)
First NDA Approval
2012
lorcaserin (belviq)
Last Known Activity
2020

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Arena Pharmaceuticals | Samia Hassan El-Shishtawy